Solid Biosciences (SLDB) Reiterated at Market Outperform by Citizens on Continued Execution

August 10, 2026 4:26 AM

Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $15.00 price target on Solid Biosciences (NASDAQ: SLDB).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found